Shanghai, November 10, 2021 –The 4th China International Import Expo (CIIE) wrapped today, creating a successful experience for Bayer, a world-leading life science company. Thanks to the “Spillover Effect” of CIIE and the platform it provides for multinational companies, Bayer has strengthened engagement with the government, industry partners, and consumers, while demonstrating our strengths in addressing the two basic needs of all people – healthcare and agriculture. Through dozens of major signing and cooperation events, Bayer collaborated with local innovative partners such as Jointown, Hainan Boao Lecheng Pilot Zone of International Medical Tourism, and Benlai.com to support China's "Dual Circulation" strategy and "Common Prosperity" goal, thus enabling Chinese patients, consumers and growers to benefit from our shared efforts.
“By participating in CIIE for four consecutive years, Bayer has witnessed China's huge demand for innovative products and high-quality services in the fields of healthcare and agriculture.” Xiaolan Zhou, Executive Vice President, President of Commercial Operations China, Bayer Pharmaceuticals; President, Bayer Group Greater China remarks, “China has always been among the most important markets for Bayer. Bayer's vision of ‘Health for All, Hunger for None’ perfectly fits with China's major national strategic goals of ‘Healthy China’, ‘Rural Revitalization’ and ‘Common Prosperity’. Next year marks the 50th anniversary of the establishment of diplomatic relations between China and Germany, and the 140th anniversary of Bayer's connection with the Chinese market. Bayer has already reserved our booth for the fifth CIIE and looks forward to working hand-in-hand with local partners to create a prosperous future – contributing to the realization of a healthier and better life for Chinese people.”